Health

Nanoparticle therapy could deliver double blow to cancer

Nanoparticle therapy could deliver double blow to cancer

A new cancer therapy using nanoparticles to deliver a combination therapy direct to cancer cells could be on the horizon, scientists say.

The therapy, which has been shown to make breast cancer and prostate cancer tumours more sensitive to chemotherapy, is now close to entering clinical trials, said researchers from the University of East Anglia (UEA) in the UK.

A study, published in the journal Scientific Reports, confirmed that it can be mass-produced, making it a viable treatment if proved effective in human trials.

Using nanoparticles to get drugs directly into a tumour is a growing area of cancer research.